Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthequity (HQY) Interest Expenses (2016 - 2026)

Healthequity has reported Interest Expenses over the past 13 years, most recently at $13.3 million for Q1 2026.

  • For Q1 2026, Interest Expenses fell 13.03% year-over-year to $13.3 million; the TTM value through Jan 2026 reached $57.1 million, down 5.78%, while the annual FY2026 figure was $57.1 million, 5.78% down from the prior year.
  • Interest Expenses for Q1 2026 was $13.3 million at Healthequity, down from $14.0 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $18.2 million in Q4 2024 and troughed at $10.5 million in Q2 2022.
  • A 5-year average of $13.7 million and a median of $13.6 million in 2024 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: surged 58.74% in 2022 and later decreased 22.62% in 2025.
  • Year by year, Interest Expenses stood at $12.2 million in 2022, then rose by 11.34% to $13.5 million in 2023, then skyrocketed by 34.03% to $18.2 million in 2024, then fell by 22.62% to $14.0 million in 2025, then decreased by 5.55% to $13.3 million in 2026.
  • Business Quant data shows Interest Expenses for HQY at $13.3 million in Q1 2026, $14.0 million in Q4 2025, and $15.0 million in Q3 2025.